Basic information Introduction Physical Properties Uses Production Reactions Safety Related Supplier
Lithium Structure

Lithium

Chemical Properties

Melting point 180 °C (lit.)
Boiling point 1342 °C (lit.)
Density  0.534 g/mL at 25 °C (lit.)
vapor pressure  1 hPa (723 °C)
storage temp.  water-free area
solubility  reacts with H2O
form  wire
Specific Gravity 0.534
color  Silvery
Odor Odorless
PH Range >12
Resistivity 9.446 μΩ-cm, 20°C
Water Solubility  REACTS
Sensitive  air sensitive, moisture sensitive
Merck  13,5542
Exposure limits ACGIH: TWA 2 ppm; STEL 4 ppm
OSHA: TWA 2 ppm(5 mg/m3)
NIOSH: IDLH 25 ppm; TWA 2 ppm(5 mg/m3); STEL 4 ppm(10 mg/m3)
Stability Stable, but reacts violently with water.
LogP -0.77 at 25℃
CAS DataBase Reference 7439-93-2(CAS DataBase Reference)
NIST Chemistry Reference Lithium(7439-93-2)
EPA Substance Registry System Lithium (7439-93-2)

Safety Information

Hazard Codes  Xi,C,F
Risk Statements  36/38-34-14/15-23
Safety Statements  8-43-45-43C-36/37/39-26
RIDADR  UN 3264 8/PG 3
WGK Germany  2
RTECS  OJ5540000
10
Autoignition Temperature 179oC
TSCA  Yes
HS Code  2805 19 90
HazardClass  4.3
PackingGroup  I
Hazardous Substances Data 7439-93-2(Hazardous Substances Data)
Toxicity An element used clinically as one of its salts. It is effective against both mania and depression. Despite its effectiveness, there are no clear mechanisms that have been directly related to its therapeutic effectiveness although its inhibition of the formation of inositol from inositol phosphate is thought to be important. At therapeutic concentrations, lithium causes almost no discernible psychotropic effects in healthy humans. The major complaints when the serum concentrations of the drug are carefully monitored include slight muscular weakness, thirst, and excessive urination. The major difficulty with lithium is that a fairly high concentration of the ion is needed in the blood (0.5_x0002_1.0 mmol/L) for maintenance, higher for acute mania. Toxic symptoms (which can involve many physiological symptoms) may occur, however, at doses of 1.5 mmol/L or higher. This low therapeutic index is indicative of the need for regular monitoring of lithium concentrations in the serum.

MSDS

Usage And Synthesis

Question and answer